Company Filing History:
Years Active: 2011-2013
Title: Fabrice Jourdan: Innovator in Tumor Growth Inhibition
Introduction
Fabrice Jourdan is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmaceutical compounds, particularly in the area of tumor growth inhibition. With a total of 2 patents to his name, his work is recognized for its potential impact on cancer treatment.
Latest Patents
Fabrice's latest patents include innovative compounds aimed at addressing critical health issues. One of his patents focuses on tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth. Another patent involves oestrogen derivatives as inhibitors of steroid sulphatase, providing a compound that includes a steroidal ring system with various substituents designed to enhance its efficacy.
Career Highlights
Fabrice Jourdan is currently associated with Sterix Limited, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Fabrice collaborates with talented professionals in his field, including Matthew Paul Leese and Atul Purohit. These partnerships enhance the innovative capacity of his projects and contribute to the success of their collective research efforts.
Conclusion
Fabrice Jourdan stands out as an influential inventor whose work in tumor growth inhibition holds promise for future medical advancements. His contributions to the field are significant and reflect a dedication to improving health outcomes through innovation.